BioSpace News Archive

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into an amendment to its previously announced transaction agreement with AiPharma Global extending the outside date by which the parties have to execute a definitive agreement from November 30, 2021 to December 16, 2021,

Hepagene Therapeutics, Inc today announced that it has screened the first patient in the USA for the RISE study, a Phase IIa clinical trial of HPG1860 in patients with non-alcoholic steatohepatitis (NASH ).

Qardio, Inc. today announced the Company’s board of directors has appointed Mike Alvarez as President and Chief Executive Officer, effective immediately.

Venatorx Pharmaceuticals today announced that Scott McConnell, Pharm.D. has joined the Company as Vice President, Medical Affairs.

In a study published in Nature genetics, scientists at deCODE genetics, a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with data on sequence diversity and RNA expression dramatically increases insights into human diseases and other phenotypes.

Petros Pharmaceuticals, Inc., a leading provider of therapeutics for men’s health, announced the closing of its previously announced registered direct offering and private placement with the company’s largest investor and other existing investors for gross proceeds of approximately 10.0 million.

Munich Reinsurance Company’s Canadian life branch (Munich Re) is pleased to announce a partnership with the McGill University Health Centre (MUHC) Foundation to advance cutting-edge cardiovascular disease research.

Pyrogens are substances that lead to causing fever after administration of an injection. Rise in the body temperature and body ache are some of the prominent reactions that are caused because of injection of these harmful pyrogens in the human body.